We are live on
!
Find out more
NFGCM
Norman Fields Gottscho Capital Management Portfolio holdings
AUM
$330M
1-Year Est. Return
27.75%
This Fund
S&P 500
This Quarter
Est. Return
-0.59%
1 Year Est. Return
+27.75%
3 Year Est. Return
+94.04%
5 Year Est. Return
+123.19%
10 Year Est. Return
+452.45%
AUM
$302M
AUM Growth
-$7.8M
(-2.5%)
Cap. Flow
-$449K
Cap. Flow
% of AUM
-0.15%
Top 10 Holdings %
Top 10 Hldgs %
71.46%
Holding
67
New
6
Increased
16
Reduced
20
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ARS Pharmaceuticals
SPRY
|
+$382K |
| 2 |
Chewy
CHWY
|
+$343K |
| 3 |
SLB Ltd
SLB
|
+$330K |
| 4 |
CAVA Group
CAVA
|
+$306K |
| 5 |
American Express
AXP
|
+$267K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.22M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$825K |
| 3 |
HOLX
Hologic
HOLX
|
+$343K |
| 4 |
Teradyne
TER
|
+$314K |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$303K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 31.74% |
| 2 | Consumer Staples | 18.94% |
| 3 | Technology | 11.83% |
| 4 | Communication Services | 10.79% |
| 5 | Industrials | 10.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Chevron
CVX
$371B
| $360K | 0.12% |
1,740
+200
| +13% | +$36.5K |
|
|
52
SLB Ltd
SLB
$76.5B
| $349K | 0.12% |
+6,800
| New | +$330K |
|
|
53
Chewy
CHWY
$9.59B
| $332K | 0.11% |
+12,300
| New | +$343K |
|
|
54
ARS Pharmaceuticals
SPRY
$551M
| $320K | 0.11% |
+39,850
| New | +$382K |
|
55
Lennar Class A
LEN
$20.4B
| $313K | 0.1% |
3,607
| – | – |
|
56
Spectrum Brands
SPB
$2.03B
| $303K | 0.1% |
4,108
-245
| -6% | -$17.5K |
|
57
Xylem
XYL
$28.2B
| $278K | 0.09% |
2,330
| – | – |
|
58
GE Aerospace
GE
$389B
| $267K | 0.09% |
940
| – | – |
|
59
Duke Energy
DUK
$96.6B
| $232K | 0.08% |
+1,774
| New | +$222K |
|
60
Automatic Data Processing
ADP
$109B
| $231K | 0.08% |
1,136
| – | – |
|
|
BNY
61
Bank of New York Mellon
BNY
$108B
| $224K | 0.07% |
1,886
| – | – |
|
62
GE Vernova
GEV
$266B
| $204K | 0.07% |
+234
| New | +$183K |
|
63
Ecolab
ECL
$79.5B
| $201K | 0.07% |
+756
| New | +$213K |
|
|
HOLX
64
DELISTED
Hologic
HOLX
| – | – |
-4,600
| Closed | -$343K |
|
Similar funds
ML
PCM
BAM
RWP
KFBMI
HLAM
GSCM
CPI
Norman Fields Gottscho Capital Management's Q1 2026 Portfolio in Review
As of Q1 2026, Norman Fields Gottscho Capital Management held 67 positions worth $302M, down 2.5% from $310M the previous quarter. Its ten largest holdings account for 71% of the portfolio.
Norman Fields Gottscho Capital Management's Q1 2026 filing shows 6 new, 16 increased, 20 reduced and 2 closed positions. Its largest new stake was ARS Pharmaceuticals: 39,850 shares worth $320K. The largest sale was Apple, an estimated $1.22M.
By sector, the portfolio is most concentrated in Financials at 32% of assets, down from 34% a quarter earlier, followed by Consumer Staples and Technology.
- Norman Fields Gottscho Capital Management's largest Q1 2026 buy was ARS Pharmaceuticals: 39,850 shares worth $320K.
- Norman Fields Gottscho Capital Management added most to CAVA Group in Q1 2026, an estimated $306K increase.
- Norman Fields Gottscho Capital Management's biggest Q1 2026 reduction was Apple, cutting an estimated $1.22M.
- Norman Fields Gottscho Capital Management fully exited Hologic in Q1 2026, selling an estimated $343K.
- Norman Fields Gottscho Capital Management's ten largest holdings make up 71% of its $302M portfolio in Q1 2026.
- Norman Fields Gottscho Capital Management opened 6 new positions and closed 2 in Q1 2026.
- Norman Fields Gottscho Capital Management's portfolio value fell 2.5% quarter-over-quarter to $302M.
Based on Norman Fields Gottscho Capital Management's 13F filing for Q1 2026, filed 2 Apr 2026.